News
Dr Susan Wyllie, Head of the Mode of Action group within WCAIR and Principal Investigator in the School of Life Sciences, underwent a successful tenure review recently.
News
Dr Susan Wyllie, Head of the Mode of Action group within WCAIR and Principal Investigator in the School of Life Sciences, underwent a successful tenure review recently.
News
Joana Faria, a postdoctoral researcher in David Horn’s Lab (BCDD-WCAIR) who is moving to establish her own group at the University of York, has been awarded the Wellcome-Beit Prize.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
Press release
Scientists at the University of Dundee have developed a new technology that provides a greater understanding into the biology of ‘undruggable’ diseases.
News
Recently published papers from the Ferguson lab describe the presence of a fucosyltransferase in the mitochondria of two protozoan parasites
News
Glycosyltransferases (GTs) are enzymes that transfer sugars from donor to an acceptor molecule. There are dozens of GT gene families, classified by sequence, sequence motifs and enzymatic function.
Press release
The expansion of an exemplary industry-academia collaboration will see the University of Dundee intensify its efforts to develop new medicines that target and destroy key cancer-causing proteins, which have previously been regarded as undruggable
News
Joana Faria, a postdoctoral researcher in David Horn’s Lab (BCDD-WCAIR) has been awarded a Sir Henry Dale Fellowship funded by the Wellcome Trust and the Royal Society.
Press release
Almost half a million rapid diagnostic tests developed from research at the University of Dundee will be donated with the aim of helping eliminate the disease known as African sleeping sickness
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.
Press release
Work to build on Dundee’s world-class expertise in biomedical sciences is set to begin in earnest after the ‘Growing the Tay Cities Biomedical Cluster’ project was officially signed off by the Tay Cities Region Joint Committee today (February 19).
News
Researchers in the Ciulli group report a first study describing the idea of a macrocyclic PROTAC. The research was published in the prestigious chemistry journal Angewandte Chemie.
Press release
The University of Dundee’s Professor David Horn has received a prestigious award in recognition of his contribution to global efforts to overcome the disease known as African sleeping sickness.
News
School of Life Science’s Professor Alessio Ciulli was amongst a selected group of world’s leading expert scientists and key opinion leaders who spoke at the Galien Forum on October 24, 2019, at the Alexandria Center in New York City.
News
DEBRA is delighted to share that funding for a fourth year of the University of Dundee’s research into novel gene technology for treating Epidermolysis Bullosa (EB) has been agreed.
News
Two academic entrepreneurs from the division of Biological Chemistry and Drug Discovery have made the final of the Converge Challenge 2019.
News
School of Life Sciences researcher Professor David Horn will receive a £2.1 million Investigator Award from Wellcome to decode gene expression mechanisms in trypanosomes, pathogenic protozoa that cause a range of human and animal diseases.
News
Dr Susan Wyllie, Head of the Mode of Action (MoA) group, has been promoted to tenure track Principal Investigator in the School.